Cleveland Clinic Cancer Center (Taussig) Outcomes
Head and Neck Cancer
Nasopharyngeal Cancer: Incidence and Prognosis of Human Papillomavirus and Epstein-Barr Virus Association at a Single North American Institution
2000-2019
The prognostication of Epstein–Barr virus (EBV) and human papillomavirus (HPV) status in nasopharyngeal cancer (NPC) is unclear. This retrospective study analyzed NPC from 2000 to 2019.
Survival Analysis Displaying Time Until Death in Patients with Primary Nasopharyngeal Cancer
2000-2019
EBV, Epstein–Barr virus; HPV, human papillomavirus.
Survival Analysis Displaying Freedom from Progression in Patients with Primary Nasopharyngeal Cancer
2000-2019
EBV, Epstein–Barr virus; HPV, human papillomavirus.
EBV+ NPC tumors were seen in younger, healthier patients than HPV+ and EBV tumors, and there were no cases of coinfection. The association of viral status with OS was insignificant after adjusting for KPS and age.
